| Members |
acceptabilityId |
| 5-aminolevulinic acid |
Preferred (foundation metadata concept) |
| 5-aminolevulinic acid (substance) |
Preferred (foundation metadata concept) |
| 5-aminolevulinic acid hydrochloride |
Acceptable (foundation metadata concept) |
| 5-aminolevulinic acid only product |
Preferred (foundation metadata concept) |
| 5-aminolevulinic acid only product in cutaneous dose form |
Preferred (foundation metadata concept) |
| 5-aminolevulinic acid only product in oral dose form |
Preferred (foundation metadata concept) |
| 5-aminolevulinic acid-containing product |
Preferred (foundation metadata concept) |
| 5-aminolevulinic acid-containing product in cutaneous dose form |
Preferred (foundation metadata concept) |
| 5-aminolevulinic acid-containing product in oral dose form |
Preferred (foundation metadata concept) |
| 5-aminopentanamidase |
Preferred (foundation metadata concept) |
| 5-aminopentanamidase (substance) |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid |
Acceptable (foundation metadata concept) |
| 5-aminosalicylic acid (substance) |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid adverse reaction |
Acceptable (foundation metadata concept) |
| 5-aminosalicylic acid adverse reaction (disorder) |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid allergy |
Acceptable (foundation metadata concept) |
| 5-aminosalicylic acid allergy |
Acceptable (foundation metadata concept) |
| 5-aminosalicylic acid overdose |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid overdose (disorder) |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid overdose of undetermined intent |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid overdose of undetermined intent (disorder) |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid poisoning |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid poisoning (disorder) |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid poisoning of undetermined intent |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid poisoning of undetermined intent (disorder) |
Preferred (foundation metadata concept) |
| 5-aminovaleramidase |
Acceptable (foundation metadata concept) |
| 5-aminovalerate aminotransferase |
Preferred (foundation metadata concept) |
| 5-aminovalerate aminotransferase (substance) |
Preferred (foundation metadata concept) |
| 5-azacytidine |
Preferred (foundation metadata concept) |
| 5-azacytidine (substance) |
Preferred (foundation metadata concept) |
| 5-beta-pregnane-3-alpha,11-beta,17,20-alpha,21-pentol |
Acceptable (foundation metadata concept) |
| 5-beta-pregnane-3-alpha,11-beta,17,20-beta,21-pentol |
Acceptable (foundation metadata concept) |
| 5-carboxymethyl-2-hydroxymuconate delta-isomerase |
Preferred (foundation metadata concept) |
| 5-carboxymethyl-2-hydroxymuconate delta-isomerase (substance) |
Preferred (foundation metadata concept) |
| 5-chloro-2-methyl-4-isothiazolin-3-one |
Preferred (foundation metadata concept) |
| 5-chloro-2-methyl-4-isothiazolin-3-one (substance) |
Preferred (foundation metadata concept) |
| 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one kathon (3:1 in water) |
Preferred (foundation metadata concept) |
| 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one kathon (3:1 in water) (substance) |
Preferred (foundation metadata concept) |
| 5-dehydro-2-deoxygluconokinase |
Preferred (foundation metadata concept) |
| 5-dehydro-2-deoxygluconokinase (substance) |
Preferred (foundation metadata concept) |
| 5-dehydro-4-deoxyglucarate dehydratase |
Preferred (foundation metadata concept) |
| 5-dehydro-4-deoxyglucarate dehydratase (substance) |
Preferred (foundation metadata concept) |
| 5-deoxyadenosylcobalamin |
Acceptable (foundation metadata concept) |
| 5-flucytosine level |
Acceptable (foundation metadata concept) |
| 5-fluorocytosine |
Acceptable (foundation metadata concept) |
| 5-fluorouracil |
Acceptable (foundation metadata concept) |
| 5-formyltetrahydrofolate cyclo-ligase |
Preferred (foundation metadata concept) |
| 5-formyltetrahydrofolate cyclo-ligase (substance) |
Preferred (foundation metadata concept) |
| 5-guanidino-2-oxopentanoate decarboxylase |
Preferred (foundation metadata concept) |
| 5-guanidino-2-oxopentanoate decarboxylase (substance) |
Preferred (foundation metadata concept) |
| 5-hydroperoxy-6,8,11,14-eicosatetraenoic acid |
Preferred (foundation metadata concept) |
| 5-hydroperoxy-6,8,11,14-eicosatetraenoic acid (substance) |
Preferred (foundation metadata concept) |
| 5-hydroxy tryptamine |
Acceptable (foundation metadata concept) |
| 5-hydroxy tryptophan |
Acceptable (foundation metadata concept) |
| 5-hydroxy-1,4-naphthoquinone |
Acceptable (foundation metadata concept) |
| 5-hydroxy-N-methylpyroglutamate synthase |
Acceptable (foundation metadata concept) |
| 5-hydroxy-alphanaphthaquinone |
Acceptable (foundation metadata concept) |
| 5-hydroxyfuranocoumarin O^5^-methyltransferase |
Preferred (foundation metadata concept) |
| 5-hydroxyfuranocoumarin O^5^-methyltransferase (substance) |
Preferred (foundation metadata concept) |
| 5-hydroxyhexanoate |
Preferred (foundation metadata concept) |
| 5-hydroxyhexanoate (substance) |
Preferred (foundation metadata concept) |
| 5-hydroxyhistamine |
Preferred (foundation metadata concept) |
| 5-hydroxyhistamine (substance) |
Preferred (foundation metadata concept) |
| 5-hydroxyindole acetic acid |
Preferred (foundation metadata concept) |
| 5-hydroxyindole acetic acid (substance) |
Preferred (foundation metadata concept) |
| 5-hydroxyindoleacetate |
Acceptable (foundation metadata concept) |
| 5-hydroxyindoleacetic acid |
Acceptable (foundation metadata concept) |
| 5-hydroxymethoxyphenamine |
Acceptable (foundation metadata concept) |
| 5-hydroxypentanoate CoA-transferase |
Preferred (foundation metadata concept) |
| 5-hydroxypentanoate coenzyme A-transferase |
Acceptable (foundation metadata concept) |
| 5-hydroxypentanoate coenzyme A-transferase (substance) |
Preferred (foundation metadata concept) |
| 5-hydroxytryptamine |
Acceptable (foundation metadata concept) |
| 5-hydroxytryptamine secreting neuroendocrine tumor |
Acceptable (foundation metadata concept) |
| 5-hydroxytryptamine secreting neuroendocrine tumor (disorder) |
Preferred (foundation metadata concept) |
| 5-hydroxytryptamine-3-receptor antagonist |
Acceptable (foundation metadata concept) |
| 5-hydroxytryptamine-3-receptor antagonist (disposition) |
Preferred (foundation metadata concept) |
| 5-hydroxytryptamine-3-receptor antagonist allergy |
Acceptable (foundation metadata concept) |
| 5-hydroxyvalerate CoA-transferase |
Acceptable (foundation metadata concept) |
| 5-iodo-2'-deoxycytidine |
Acceptable (foundation metadata concept) |
| 5-item World Health Organization Well-being Index questionnaire |
Preferred (foundation metadata concept) |
| 5-item World Health Organization Well-being Index questionnaire (assessment scale) |
Preferred (foundation metadata concept) |
| 5-item World Health Organization Well-being Index value |
Preferred (foundation metadata concept) |
| 5-item World Health Organization Well-being Index value (observable entity) |
Preferred (foundation metadata concept) |
| 5-keto-2-deoxygluconokinase |
Acceptable (foundation metadata concept) |
| 5-keto-D-fructose reductase |
Acceptable (foundation metadata concept) |
| 5-keto-D-fructose reductase (NADP^+^) |
Acceptable (foundation metadata concept) |
| 5-keto-D-gluconate 2-reductase |
Acceptable (foundation metadata concept) |
| 5-keto-D-gluconate 5-reductase |
Acceptable (foundation metadata concept) |
| 5-keto4-deoxy-glucarate dehydratase |
Acceptable (foundation metadata concept) |
| 5-lipoxygenase inhibitor |
Preferred (foundation metadata concept) |
| 5-lipoxygenase inhibitor |
Preferred (foundation metadata concept) |
| 5-lipoxygenase inhibitor (disposition) |
Preferred (foundation metadata concept) |
| 5-lipoxygenase inhibitor-containing product |
Preferred (foundation metadata concept) |
| 5-methoxypsoralen |
Preferred (foundation metadata concept) |
| 5-methoxypsoralen (substance) |
Preferred (foundation metadata concept) |
| 5-methoxypsoralen only product |
Preferred (foundation metadata concept) |
| 5-methoxypsoralen-containing product |
Preferred (foundation metadata concept) |
| 5-methyl-3-heptanone |
Preferred (foundation metadata concept) |
| 5-methyl-3-heptanone (substance) |
Preferred (foundation metadata concept) |
| 5-methyl-8-quinolinol |
Acceptable (foundation metadata concept) |
FHIR